Back
ALLIANCE PHARMA INVESTMENT - UPDATE
LDG plc
("LDG", the "Company" or, with its subsidiaries, the "Group")
Alliance Pharma Investment - Update
LDG is pleased to note that the boards of Aegros Bidco Limited ("Bidco") and Alliance Phave reached an agreement on the terms of a recommended acquisition at 62.5p per ordinthe capital of Alliance ("Alliance Shares") in cash, valuing Alliance's issued share capital made by Bidco for the entire issued share capital of Alliance, other than the Alliance Shareor managed by DBAY Advisors Limited ("DBAY"), the Company's investment managerShares in which LDG is interested as noted below (the "Acquisition"). The Acquisiimplemented by means of a Court-sanctioned scheme of arrangement.
Read more below
Read the full report
View PDF
10 January 2025
Investment